ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
6,047.15
0.81%
Dow Jones
44,782.00
-0.29%
US Dollar vs MXN
20.405
-0.04%
Brent Oil
71.905
0.02%
Bitcoin
96,093.34
0.24%
Pepperstone
Advertisement
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Onconova Therapeutics Inc (ONTX)

  7. Onconova Therapeutics Inc (ONTX) Noticias

ONTX

Onconova Therapeutics (ONTX)

Onconova Therapeutics Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:ONTX
FechaHoraFuenteTítuloSímboloCompañía
09/02/202416:38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONTXOnconova Therapeutics Inc
08/02/202415:09Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ONTXOnconova Therapeutics Inc
27/10/202315:35Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ONTXOnconova Therapeutics Inc
29/09/202316:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ONTXOnconova Therapeutics Inc
14/08/202316:28Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ONTXOnconova Therapeutics Inc
21/07/202315:50Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ONTXOnconova Therapeutics Inc
11/07/202323:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ONTXOnconova Therapeutics Inc
30/06/202315:46Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:ONTXOnconova Therapeutics Inc
13/06/202315:55Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ONTXOnconova Therapeutics Inc
07/06/202315:31Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ONTXOnconova Therapeutics Inc
15/05/202316:29Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ONTXOnconova Therapeutics Inc
30/03/202315:47Edgar (US Regulatory)Annual Report (10-k)NASDAQ:ONTXOnconova Therapeutics Inc
19/12/202217:53Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ONTXOnconova Therapeutics Inc
15/11/202215:32Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ONTXOnconova Therapeutics Inc
15/11/202207:25TipRanksNoble Financial Keeps Their Buy Rating on Onconova Therapeutics (ONTX)NASDAQ:ONTXOnconova Therapeutics Inc
15/11/202205:16TipRanksH.C. Wainwright Keeps Their Hold Rating on Onconova Therapeutics (ONTX)NASDAQ:ONTXOnconova Therapeutics Inc
13/09/202207:05TipRanksNoble Financial Sticks to Their Buy Rating for Onconova Therapeutics (ONTX)NASDAQ:ONTXOnconova Therapeutics Inc
12/08/202205:26TipRanksH.C. Wainwright Sticks to Their Hold Rating for Onconova Therapeutics (ONTX)NASDAQ:ONTXOnconova Therapeutics Inc
13/05/202215:22Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ONTXOnconova Therapeutics Inc
12/05/202207:05TipRanksNoble Financial Remains a Buy on Onconova Therapeutics (ONTX)NASDAQ:ONTXOnconova Therapeutics Inc
12/05/202205:15TipRanksOnconova Therapeutics (ONTX) Gets a Hold Rating from H.C. WainwrightNASDAQ:ONTXOnconova Therapeutics Inc
29/04/202216:04Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:ONTXOnconova Therapeutics Inc
04/04/202207:25TipRanksAnalysts Offer Insights on Healthcare Companies: Onconova Therapeutics (ONTX), Baudax Bio (BXRX) and 4d Pharma (LBPS)NASDAQ:ONTXOnconova Therapeutics Inc
21/03/202207:25TipRanksNoble Financial Thinks Onconova Therapeutics’ Stock is Going to RecoverNASDAQ:ONTXOnconova Therapeutics Inc
18/03/202205:17TipRanksH.C. Wainwright Sticks to Its Hold Rating for Onconova Therapeutics (ONTX)NASDAQ:ONTXOnconova Therapeutics Inc
14/02/202214:21Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ONTXOnconova Therapeutics Inc
02/12/202110:35TipRanksOnconova Therapeutics (ONTX) Receives a Hold from H.C. WainwrightNASDAQ:ONTXOnconova Therapeutics Inc
01/10/202110:02Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ONTXOnconova Therapeutics Inc
28/09/202115:05GlobeNewswire Inc.Onconova Therapeutics, Inc. Announces Closing of $21 Million Public Offering of Common StockNASDAQ:ONTXOnconova Therapeutics Inc
24/09/202107:00GlobeNewswire Inc.Onconova Therapeutics, Inc. Announces Pricing of $21 Million Public Offering of Common StockNASDAQ:ONTXOnconova Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:ONTX

Su Consulta Reciente

NASDAQ
QQQ
Invesco QQQ Trust Series 1
AMEX
SPY
SPDR S&P 500
NASDAQ
GOOGL
Alphabet
USOTC
ADDYY
Adidas (QX)
NASDAQ
TSLA
Tesla
NYSE
MRK
Merck
NYSE
VZ
Verizon Communications
AMEX
XLE
Energy Select Sector SPDR
COIN
SOLUSD
Solana
COIN
AVAXUSD
Avalanche
CCOM
SILVER
SILVER
NYSE
KO
Coca Cola
AMEX
XLF
Financial Select Sector
COIN
DOGEUSD
Dogecoin
CCOM
OILBRENT
Brent Oil
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados

BLACK FRIDAY

ADVFN

Celebrando 25 años Est 1999-2024

Ahorra hasta 60%* en Forex

1 año 40%, 2 años 40% y *3 años 60%

*Durante 3 años $1.035.00 solo $414.00